Skip to main content

Security report for fortislife.com

Fortis Life Sciences, LLC · Healthcare · United States

Medium risk. 5 critical or high findings in Security headers, GDPR outside view and 1 other check.

Security score

69/100

Risk levelMedium

0–100, higher is better. How it is calculated

Fortis Life Sciences, LLC is a medium-sized company operating in the healthcare sector, specializing in life sciences and diagnostics. The company offers a broad portfolio of products and services including reagents, diagnostic components, CDMO services, contract research and development, and biopharma solutions. Their website positions them as a trusted partner for life science and diagnostics companies, emphasizing integrated solutions designed to support complex development challenges and innovation scaling. The company targets B2B customers in research, diagnostics, and therapeutic markets. Technically, the website is built using modern web technologies such as React and Next.js, with Builder.io as the CMS platform. It employs Google reCAPTCHA for form security and loads efficiently with good mobile optimization and SEO practices. However, some security headers are missing, and there is no explicit cookie consent mechanism or detailed security policy published on the site. From a security perspective, the site uses HTTPS with a strong SSL configuration and implements bot protection on forms. The absence of WHOIS domain registration data raises concerns about domain legitimacy, although the professional website content and presence on LinkedIn support the business's credibility. No critical vulnerabilities or exposed sensitive data were detected. Overall, the website presents a professional and trustworthy front for Fortis Life Sciences, but improvements in domain registration transparency, security headers, and privacy compliance would enhance trust and security posture. Strategic recommendations include implementing security headers, publishing incident response and vulnerability disclosure policies, and adding cookie consent mechanisms to align with privacy regulations.

Scanned

NIS2 and GDPR posture

GDPR outside view
58/ 100 · Medium
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

5 findings rated critical or high. Fix these first.

  1. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing X-Frame-Options header

      Prevents clickjacking attacks

      What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

  2. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • High

      No Cookie Policy found

      GDPR requires clear information about cookie usage

      What to do: Add a dedicated cookie policy explaining cookie usage and purposes

    • High

      No Cookie Consent Banner found

      GDPR requires explicit consent for non-essential cookies

      What to do: Implement a cookie consent banner that appears on first visit

  3. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1

Need hands-on remediation? Email guard@offseq.com

Keep watching fortislife.com

This scan found 23 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. See sample alerts.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
72
Security headers
30
Email security
75
DNS health
80
Network security
100
GDPR outside view
58
Average
69

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

Fortis Life Sciences operates in a competitive healthcare market, focusing on life sciences reagents and diagnostics. Their integrated service and product offerings provide a competitive advantage by addressing multiple customer needs from product supply to custom development and manufacturing. The business model is primarily B2B, targeting research institutions, diagnostic companies, and biopharma firms. The company demonstrates growth potential through diversified services such as nanoparticle synthesis and spatial biology. Their partnership ecosystem includes digital presence on LinkedIn, but no explicit partner domains were identified. The lack of WHOIS data suggests a need for improved domain management to avoid trust issues. Overall, Fortis Life Sciences appears well-positioned with a clear market focus and professional digital presence.

Security posture

The website demonstrates a moderate security maturity level with HTTPS enforced and Google reCAPTCHA protecting forms. However, the absence of key security headers such as Content-Security-Policy and X-Frame-Options reduces defense-in-depth. No explicit security or incident response policies are published, which may impact compliance with regulations like GDPR or NIS2. The lack of a vulnerability disclosure policy or security.txt file limits transparency and responsiveness to security issues. No exposed sensitive data or vulnerable libraries were detected, indicating good baseline security hygiene. To improve, the company should implement recommended security headers, publish security policies, and enhance privacy compliance mechanisms.

Recommendations

  1. Implement comprehensive security headers including Content-Security-Policy, X-Frame-Options, and X-XSS-Protection.
  2. Publish an incident response plan and vulnerability disclosure policy accessible on the website.
  3. Add a cookie consent banner or mechanism to comply with privacy regulations.
  4. Ensure domain WHOIS information is complete and publicly available to improve trustworthiness.
  5. Regularly audit third-party scripts and dependencies for vulnerabilities and update accordingly.

Contact details published on the site

Addresses
Legal name
Fortis Life Sciences, LLC
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Fortis Life Sciences, LLC
Description
Fortis Life Sciences offers world-class reagents, tools, materials, and custom services for research, diagnostic and therapeutic customers.
Key services
Products, CDMO Services, Contract Research & Development, Diagnostic Solutions, Biopharma Solutions, Nanoparticle Synthesis & Manufacturing, Spatial Biology Services, VHH Discovery
Content quality
good
Branding
consistent

Technology

Stack
React, Next.js, Google reCAPTCHA, Builder.io
Frameworks
Next.js
Performance
moderate
Mobile
good
Accessibility
basic
SEO
good

Security

Observed score
85/100
Good practices seen
  • HTTPS enabled
  • Google reCAPTCHA implemented on forms

Analytics and tracking

Tracking level
minimal
Privacy practices
basic

Advertising

Tracking pixels
builder.io pixel
Marketing tools
Google reCAPTCHA
Transparency
basic

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is fully accessible with rich content and professional design
  2. No WAF or blocking mechanisms detected
  3. WHOIS data missing, domain registration status unclear
  4. Privacy and terms policies present and accessible
  5. Contact information is clear and includes phone, address, and contact forms
  6. No explicit security policy or incident response information found
  7. No vulnerability disclosure or security.txt file detected
  8. Use of modern web technologies and CMS (Builder.io, Next.js)
  9. Google reCAPTCHA used for bot protection on forms
  10. No suspicious or malicious external domains detected
Technical notes

Notes

The website is built on a modern React/Next.js framework with Builder.io CMS integration, enabling dynamic content management and responsive design. Google reCAPTCHA is used for bot mitigation on forms. The site loads multiple fonts from Google Fonts and images from a CDN, optimizing performance. However, no explicit hosting provider or server details were detected. Accessibility features are basic but present, and SEO meta tags are well implemented. Performance is moderate with room for improvement in caching and security header implementation. The technical stack supports scalability and good user experience but requires enhancements in security and privacy compliance.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with fortislife.com. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review fortislife.com.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.